Volume 1, Issue 9
Editorialp. 1199
Optimism and oncology trials: help or hindrance?
Author(s): Blair Henry, Michael Szego
Editorialp. 1203
How to advance medical research: less regulation, more money and more specific strategies?
Author(s): OA Cornely, D Arenz
Editorialp. 1207
Why antidepressant clinical trials fail: the role of expectations
Author(s): Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Proceedingsp. 1217
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Author(s): Kate Bushby, Edward Connor
Clinical Trail Outcomesp. 1237
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Author(s): Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomesp. 1251
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
Author(s): John D Carroll, Bray Patrick-Lake
Therapeutic Prospectivep. 1257
Chemoprevention of prostate cancer: is there evidence from clinical trials?
Author(s): Marcelo Langer Wroclawski, Cynthia Kuk, Antonio Finelli, Neil E Fleshner, Alexandre R Zlotta
Therapeutic Prospectivep. 1269
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
Author(s): David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Review Articlep. 1279
Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress
Author(s): Monica Millan, Antoni Davalos
Review Articlep. 1291
Biologic monotherapy for the treatment of rheumatoid arthritis
Author(s): Andrew Taylor, Graeme Jones
Review Articlep. 1301
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Author(s): Gregor Hron, Andreas Greinacher
Review Articlep. 1315
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Author(s): Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Articlep. 1329
Denosumab for treatment of osteoporosis in postmenopausal women
Author(s): Ove Torring
Acknowledgementsp. 1341
